Results:HER-2/neu, P53, ER and PR were found to be with the positive rates of 18.4% (14/76), 36.8%(28/76), 27.6% ( 21/76) and 25%(19/76) respectively in cervical adenocarcinoma.
Results The positive rates of HPV16/18DNA and COX-2 protein in cervical adenocarcinoma were 65.1% and 86.0% respectively,which significantly higher than that in cervical chronic inflammation 8.3% and 33.3% (P< 0.01 ).
Objective To investigate the expression of nuclear factor-kappa B(NF-κB) in human cervical squamous carcinoma tissues and cervical adenocarcinoma tissues.
Methods: The expression of survivin,CD_(44v6) and MMP-2 was examined by immunohistochemical method and color pathological image computer analysis system in 10 cases of normal cervical epithelia,10 cases of cervical carcinoma in situ,40 cases of invasive squamous cell carcinoma of cervix and 11 cases of invasive adenocarcinoma of cervix. The relationship between those expression outcomes and to the characteristics of clinical pathology of cervical carcinoma was analyzed statistically.
To explore the molecular mechanisms involved in the anticancer activity of triptolide, we have examined the effect of triptolide on the growth of pancreatic carcinoma PANC-1 and cervical adenocarcinoma HeLa cells.
To evaluate the efficacy and toxicity of the combination of mitomycin C, etoposide, cisplatin, and epirubicin (MEPA) as neoadjuvant therapy for patients with cervical adenocarcinoma.